Evidence map›Paper›PMID 27826040›Full record

ArticleCancer letters2017

Dying glioma cells establish a proangiogenic microenvironment through a caspase 3 dependent mechanism.

Xiao Feng, Yang Yu, Sijia He, Jin Cheng, Yanping Gong, Zhengxiang Zhang, Xuguang Yang, Bing Xu, Xinjian Liu, Chuan-Yuan Li and 2 more

Abstract read
In one paragraph

Article in Cancer letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 192 citations in OpenAlex.

  1. Flexible nursing in patients with lung cancer who received chemotherapy.Journal of cancer research and clinical oncology · 2023
    Trial
  2. Anastasis: an unwelcome guest in cancer therapy.Apoptosis : an international journal on programmed cell death · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. The concealed side of caspases: beyond a killer of cells.Cellular and molecular life sciences : CMLS · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Xiao FengThe Comprehensive Cancer Center and Shanghai Key Laboratory for Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.
Yang YuThe Comprehensive Cancer Center and Shanghai Key Laboratory for Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.
Sijia HeThe Comprehensive Cancer Center and Shanghai Key Laboratory for Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.
Jin ChengThe Comprehensive Cancer Center and Shanghai Key Laboratory for Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.
Yanping GongThe Comprehensive Cancer Center and Shanghai Key Laboratory for Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.
Zhengxiang ZhangThe Comprehensive Cancer Center and Shanghai Key Laboratory for Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.
Xuguang YangThe Comprehensive Cancer Center and Shanghai Key Laboratory for Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.
Bing XuThe Comprehensive Cancer Center and Shanghai Key Laboratory for Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.
Xinjian LiuThe Comprehensive Cancer Center and Shanghai Key Laboratory for Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.
Chuan-Yuan LiThe Department of Dermatology, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: chuan.li@duke.edu.
Ling TianInstitute of Translational Medicine and Shanghai Key Laboratory for Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China. Electronic address: tl09168@hotmail.com.
Qian HuangThe Comprehensive Cancer Center and Shanghai Key Laboratory for Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China. Electronic address: qhuang@sjtu.edu.cn.
Shanghai First People's Hospital · CNShanghai Jiao Tong University · CNDuke University Hospital · US

Funding

Pro-oncogenic roles of apoptotic caspasesR01ES024015 · NIEHS · DUKE UNIVERSITY · PI LI, CHUAN-YUAN · 2014 to 2018
$1.8M
The "Phoenix Rising" pathway of tumor repopulation during radiotherapyR01CA155270 · NCI · DUKE UNIVERSITY · PI LI, CHUAN-YUAN · 2011 to 2015
$1.6M
NCI NIH HHS R01 CA155270NIEHS NIH HHS R01 ES024015
6 · The paper itself

Abstract

Vascular recovery or re-angiogenesis after radiotherapy plays a significant role in tumor recurrence, whereas molecular mechanisms of this process remain elusive. In this work, we found that dying glioma cells promoted post-irradiation angiogenesis through a caspase 3 dependent mechanism. Evidence in vitro and in vivo indicated that caspase 3 inhibition undermined proangiogenic effects of dying glioma cells. Proteolytic inactivation of caspase 3 in glioma cells reduced tumorigenicity. Importantly, we identified that NF-κB/COX-2/PGE

Indexed as

Neovascularization, PathologicTumor MicroenvironmentAngiogenesis InhibitorsAnimalsBrain NeoplasmsCaspase 3Caspase InhibitorsCell DeathCell Line, TumorCyclooxygenase 2DinoprostoneDose-Response Relationship, RadiationEnzyme ActivationEukaryotic Initiation Factor-4EFemaleGliomaAngiogenesis InhibitorsCASP3 protein, humanCaspase 3Caspase InhibitorsCyclooxygenase 2DinoprostoneEukaryotic Initiation Factor-4ENF-kappa BPTGS2 protein, humanVascular Endothelial Growth Factor AVEGFA protein, humanAngiogenesisCaspase 3COX-2/PGE(2)IrradiationVEGF-A

Identifiers

PMID27826040
PMCPMC5323266
OpenAlexW2546422624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.